Skip to content
2000
Volume 2, Issue 3
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Not only a high level of low-density lipoprotein (LDL) cholesterol, but also a low level of highdensity lipoprotein (HDL) cholesterol, is a critical risk factor for atherosclerosis and coronary heart disease. Although fibrates and niacin can be used to improve low HDL cholesterol levels, their effect is not wholly satisfactory, so better drugs for the elevation of HDL cholesterol are desired. Among the many methods that may be used to raise HDL cholesterol levels, this review focuses on inhibitors of cholesteryl ester transfer protein (CETP) and on nuclear orphan receptor agonists that mediate the expression of ATP-binding cassette transporter 1 (ABC1).

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557023406115
2002-06-01
2025-09-10
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557023406115
Loading

  • Article Type:
    Review Article
Keyword(s): abc1; cetp inhibitor; hdl; hdl cholesterol
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test